SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-19-014652
Filing Date
2019-03-14
Accepted
2019-03-13 20:18:38
Documents
84
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a19-30142_110k.htm 10-K 1909695
2 EX-21.1 a19-30142_1ex21d1.htm EX-21.1 3577
3 EX-23.1 a19-30142_1ex23d1.htm EX-23.1 4235
4 EX-31.1 a19-30142_1ex31d1.htm EX-31.1 12651
5 EX-31.2 a19-30142_1ex31d2.htm EX-31.2 12591
6 EX-32.1 a19-30142_1ex32d1.htm EX-32.1 6174
7 EX-32.2 a19-30142_1ex32d2.htm EX-32.2 6152
  Complete submission text file 0001104659-19-014652.txt   8463050

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ctrv-20181231.xml EX-101.INS 1843532
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20181231.xsd EX-101.SCH 69440
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20181231_cal.xml EX-101.CAL 53873
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20181231_def.xml EX-101.DEF 288267
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20181231_lab.xml EX-101.LAB 600277
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20181231_pre.xml EX-101.PRE 457358
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36856 | Film No.: 19679536
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1